Scibase Holding Investor Relations Material
Latest events
CMD 2024
Scibase Holding
Q1 2025
13 May, 2025
Q4 2024
25 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Scibase Holding
Access all reports
SciBase Holding AB is a medical technology company specializing in the development and commercialization of point-of-care diagnostic platforms. These platforms, such as Nevisense and Nevisense Go, utilize electrical impedance spectroscopy (EIS) to assess skin disorders, including melanoma and non-melanoma skin cancers, as well as skin barrier function and inflammation. The company is headquartered in Sundbyberg, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SCIB
Country
🇸🇪 Sweden